Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development Daiichi Sankyo appoints Antoine Yver as Global Head, Oncology Research and Development He will lead all global R&D across the oncology therapeutic area New Technical Officer for ReFaC New Technical Officer for ReFaC Kim Shillington joins the UK firm ESMO appoints first Chief Medical Officer ESMO appoints first Chief Medical Officer New position reflects ESMO’s rapid growth and follows extensive six-month selection process Paragon Bioservices appoints Bill Thomas as Chief Technology Officer Paragon Bioservices appoints Bill Thomas as Chief Technology Officer Vaccines industry veteran was most recently with MassBiologics Cypralis hires Dr Michael Peel as Chief Scientific Officer Cypralis hires Dr Michael Peel as Chief Scientific Officer He joins the UK life sciences firm from Scynexis, where he was Director of Discovery Valeant Pharmaceuticals makes management change Valeant Pharmaceuticals makes management change In its US Dermatology and Gastrointestinal businesses Rigel names Anne-Marie Duliege as Chief Medical Officer Rigel names Anne-Marie Duliege as Chief Medical Officer Elliott Grossbard retires but will continue advising on NDA filing for fostamatinib New Chief Medical Officer at Arvinas New Chief Medical Officer at Arvinas Angela Shen brings extensive experience in clinical development, medical affairs and business development to the firm HUYA Bioscience appoints John Ratliff as President and CEO HUYA Bioscience appoints John Ratliff as President and CEO He was previously President/COO of Quintiles' Global Services organisation Onxeo establishes US subsidiary Onxeo establishes US subsidiary Pharmaceutical and biotech industry veteran, Philippe Maitre, will head the new venture Sanofi appoints Dr Yong-Jun Liu as Head of Research Sanofi appoints Dr Yong-Jun Liu as Head of Research He will be responsible for leading all of Sanofi's research with the goal of delivering innovative and high-value medicines for patients Quay Pharma celebrates apprentice success Quay Pharma celebrates apprentice success The firm's Apprenticeship Scheme has made an important contribution to the ongoing growth and development of its business Michael Luther joins Bantam Pharmaceutical as President and CEO Michael Luther joins Bantam Pharmaceutical as President and CEO Prior to this he was SVP and General Manager for the Discovery and Development Services Division of Albany Molecular Research Two executives join Transgene leadership team Two executives join Transgene leadership team Maud Brandely and John Felitti join the French firm Sosei appoints Peter Bains as COO and President elect Sosei appoints Peter Bains as COO and President elect He is expected to become Representative Executive Officer, President and Chief Executive at the AGM in June F-star moves into new facility in Cambridge, UK F-star moves into new facility in Cambridge, UK Also expands team with appointment of Michael Davies as VP Protein Sciences Novavax makes management promotions Novavax makes management promotions Also appoints Bob Darius as SVP, Quality Operations Kymab appoints Dr David Chiswell as Chief Executive Kymab appoints Dr David Chiswell as Chief Executive Steps up from interim CEO of the Cambridge, UK-based firm Two new appointments at BASF in the UK & Ireland Two new appointments at BASF in the UK & Ireland Richard Carter and Darren Budd take on new roles at the chemicals giant New Chief Executive and Chairman for Asterias Biotherapeutics New Chief Executive and Chairman for Asterias Biotherapeutics Stephen Cartt and Don Bailey join the US biopharmaceutical firm Pherecydes Pharma appoints Guy-Charles Fanneau de La Horie as Chief Executive Pherecydes Pharma appoints Guy-Charles Fanneau de La Horie as Chief Executive He joins the firm to secure funding and further develop phage therapy to fight bacterial infections Ubiquigent strengthens team Ubiquigent strengthens team And enhances its drug discovery service capabilities Spero Therapeutics hires Cristina Larkin as Chief Commercial Officer Spero Therapeutics hires Cristina Larkin as Chief Commercial Officer Her expertise covers various infectious disease products Ideal Cures expands global reach with a presence in America Ideal Cures expands global reach with a presence in America Appoints Kamlesh Oza as President – Global Business Development